- Home
- GPCR vs SCS Comparison
GPCR vs SCS Comparison
Compare GPCR & SCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GPCR
- SCS
- Stock Information
- Founded
- GPCR 2016
- SCS 1912
- Country
- GPCR United States
- SCS United States
- Employees
- GPCR N/A
- SCS N/A
- Industry
- GPCR
- SCS Office Equipment/Supplies/Services
- Sector
- GPCR
- SCS Consumer Discretionary
- Exchange
- GPCR Nasdaq
- SCS Nasdaq
- Market Cap
- GPCR 1.1B
- SCS 1.2B
- IPO Year
- GPCR 2023
- SCS 1998
- Fundamental
- Price
- GPCR $17.59
- SCS $10.17
- Analyst Decision
- GPCR Strong Buy
- SCS Buy
- Analyst Count
- GPCR 7
- SCS 1
- Target Price
- GPCR $76.17
- SCS $16.00
- AVG Volume (30 Days)
- GPCR 734.9K
- SCS 851.8K
- Earning Date
- GPCR 08-11-2025
- SCS 09-17-2025
- Dividend Yield
- GPCR N/A
- SCS 3.93%
- EPS Growth
- GPCR N/A
- SCS 37.12
- EPS
- GPCR N/A
- SCS 1.04
- Revenue
- GPCR N/A
- SCS $3,217,700,000.00
- Revenue This Year
- GPCR N/A
- SCS $4.30
- Revenue Next Year
- GPCR N/A
- SCS $3.51
- P/E Ratio
- GPCR N/A
- SCS $9.78
- Revenue Growth
- GPCR N/A
- SCS 2.64
- 52 Week Low
- GPCR $13.22
- SCS $9.32
- 52 Week High
- GPCR $45.37
- SCS $14.64
- Technical
- Relative Strength Index (RSI)
- GPCR 31.53
- SCS 43.26
- Support Level
- GPCR $17.45
- SCS $10.44
- Resistance Level
- GPCR $18.78
- SCS $10.95
- Average True Range (ATR)
- GPCR 0.82
- SCS 0.29
- MACD
- GPCR 0.00
- SCS -0.03
- Stochastic Oscillator
- GPCR 5.00
- SCS 13.74
About GPCR Structure Therapeutics Inc.
Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.
About SCS Steelcase Inc.
Steelcase Inc is a furniture company based in the United States. Its brands, such as Steelcase, AMQ, Coalesse, Designtex, and others, offer a portfolio of furniture and architectural products and services designed to help customers create workplaces. It markets its products and services to businesses and organizations predominantly through a network of dealers and also sells to consumers in markets around the world through web-based and retail distribution channels. The company's reportable segments include the Americas, which generates key revenue, and the International segment.